aP components were combined with diphtheria (D) and tetanus (T) toxoids into DTaP trivalent vaccine, and the immunogenicity and the protective efficacy of raP and aP were compared in an experimental murine immunization and challenge model using InfanrixTM as a comparator vaccine (control). This evidence concerns the gene LRPAP1 and tetanus.